What is Citalid?
Citalid offers a sophisticated software solution designed to empower companies in evaluating their exposure to cyber risks. The platform enables organizations to prioritize their defense and insurance strategies effectively, while also simulating the potential returns on these investments. This approach allows businesses to make more informed decisions regarding their cybersecurity posture and financial planning.
How much funding has Citalid raised?
Citalid has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2022): $12M with participation from Relyens en France, Seventure Partners, Axeleo Capital, and BNP Paribas Development
Key Investors in Citalid
Relyens en France
Relyens en France is an insurance specialist focused on risk management and prevention for public sector entities and healthcare institutions, aiming to enhance safety and efficiency in care delivery.
Seventure Partners
Seventure Partners is a venture capital firm that actively supports innovative companies in digital technologies and life sciences, investing across health, nutrition, fintech, and sustainable initiatives.
Axeleo Capital
Axeleo Capital is an investment firm that supports technology startups. Their focus is on early-stage companies, providing them with the necessary capital and strategic guidance to scale their operations and achieve market leadership.
What's next for Citalid?
The substantial enterprise-level funding, particularly the recent Series A round, positions Citalid for accelerated growth and market expansion. This capital infusion is expected to fuel further development of its innovative risk assessment tools, enhance its go-to-market strategies, and potentially explore new verticals within the cybersecurity and risk management landscape. The company's focus on integrating financial returns with risk mitigation strategies suggests a strategic direction aimed at providing tangible business value beyond mere security.
See full Citalid company page
